HydraDAO, which funds research to extend human lifespan, announced it raised $4.10 million through a HYDRA token sale.
HydraDAO is designed to provide humans with biological replacement parts, including whole-body replacements, for maximum lifespan.
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.